{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Carbazole", "cancer", "cytotoxicity", "enzyme inhibitors", "targeted therapy"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "31328585", "DateCompleted": {"Year": "2019", "Month": "07", "Day": "30"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "25"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1080/14756366.2019.1640692"], "Journal": {"ISSN": "1475-6374", "JournalIssue": {"Volume": "34", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Dec"}}, "Title": "Journal of enzyme inhibition and medicinal chemistry", "ISOAbbreviation": "J Enzyme Inhib Med Chem"}, "ArticleTitle": "Carbazole scaffolds in cancer therapy: a review from 2012 to 2018.", "Pagination": {"StartPage": "1321", "EndPage": "1346", "MedlinePgn": "1321-1346"}, "Abstract": {"AbstractText": ["For over half a century, the carbazole skeleton has been the key structural motif of many biologically active compounds including natural and synthetic products. Carbazoles have taken an important part in all the existing anti-cancer drugs because of their discovery from a large variety of organisms, including bacteria, fungi, plants, and animals. In this article, we specifically explored the literature from 2012 to 2018 on the anti-tumour activities reported to carbazole derivatives and we have critically collected the most significant data. The most described carbazole anti-tumour agents were classified according to their structure, starting from the tricyclic-carbazole motif to fused tetra-, penta-, hexa- and heptacyclic carbazoles. To date, three derivatives are available on the market and approved in cancer therapy."]}, "AuthorList": [{"Identifier": ["0000-0003-2446-3512"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Ecole de Biologie Industrielle, EBInnov , Cergy-Pontoise , France."}], "LastName": "Issa", "ForeName": "Samar", "Initials": "S"}, {"Identifier": ["0000-0002-7624-7654"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "b Facult\u00e9 de Pharmacie - ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Sant\u00e9 Lyon-Est CNRS UMS3453 - INSERM US7, Universit\u00e9 de Lyon, Universit\u00e9 Claude Bernard Lyon 1 , Lyon , France."}, {"Identifier": [], "Affiliation": "c Department of Pharmaceutical Chemistry, School of Pharmacy, University of Oslo , Oslo , Norway."}], "LastName": "Prandina", "ForeName": "Anthony", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "b Facult\u00e9 de Pharmacie - ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Sant\u00e9 Lyon-Est CNRS UMS3453 - INSERM US7, Universit\u00e9 de Lyon, Universit\u00e9 Claude Bernard Lyon 1 , Lyon , France."}], "LastName": "Bedel", "ForeName": "Nicolas", "Initials": "N"}, {"Identifier": ["0000-0001-6678-1952"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "c Department of Pharmaceutical Chemistry, School of Pharmacy, University of Oslo , Oslo , Norway."}], "LastName": "Rongved", "ForeName": "P\u00e5l", "Initials": "P"}, {"Identifier": ["0000-0001-9221-6535"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "d Universit\u00e9 Lille, Inserm, CHU Lille, UMR-S 1172 JPArc Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer , Lille , France."}], "LastName": "Yous", "ForeName": "Sa\u00efd", "Initials": "S"}, {"Identifier": ["0000-0003-1398-075X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "b Facult\u00e9 de Pharmacie - ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Sant\u00e9 Lyon-Est CNRS UMS3453 - INSERM US7, Universit\u00e9 de Lyon, Universit\u00e9 Claude Bernard Lyon 1 , Lyon , France."}], "LastName": "Le Borgne", "ForeName": "Marc", "Initials": "M"}, {"Identifier": ["0000-0002-9948-0272"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "b Facult\u00e9 de Pharmacie - ISPB, EA 4446 Bioactive Molecules and Medicinal Chemistry, SFR Sant\u00e9 Lyon-Est CNRS UMS3453 - INSERM US7, Universit\u00e9 de Lyon, Universit\u00e9 Claude Bernard Lyon 1 , Lyon , France."}], "LastName": "Bouaziz", "ForeName": "Zouhair", "Initials": "Z"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Enzyme Inhib Med Chem", "NlmUniqueID": "101150203", "ISSNLinking": "1475-6366"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Carbazoles"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Carbazoles"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Neoplasms"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "WHO methods and data sources for global burden of disease estimates 2000\u20132015 , Department of information, evidence and research WHO, Geneva, January 2017, available at http://www.who.int/healthinfo/global_burden_disease/GlobalDALYmethods_2000_2015.pdf [last accessed 26 Jul 2018]."}, {"Citation": "Ferlay J, Soerjomataram I, Dikshit R, et al. . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359\u201386.", "ArticleIdList": ["25220842"]}, {"Citation": "Schmidt AW, Reddy KR, Kn\u00f6lker H-J. Occurrence, biogenesis, and synthesis of biologically active carbazole alkaloids. Chem Rev 2012;112:3193\u2013328.", "ArticleIdList": ["22480243"]}, {"Citation": "Kn\u00f6lker H-J, Reddy KR. Isolation and synthesis of biologically active carbazole alkaloids. Chem Rev 2002;102:4303\u2013427.", "ArticleIdList": ["12428991"]}, {"Citation": "Graebe C, Glazer C. First isolation of carbazole from coal tar. Ber Dtsch Chem Ges 1872;5:12."}, {"Citation": "Chakraborty DP, Roy S, Carbazole alkaloids IV In: Fortschritte der Chemie organischer Naturstoffe/Progress in the Chemistry of Organic Natural Products. Wien GmbH: Springer-Verlag; 2003; vol. 85:125\u2013230.", "ArticleIdList": ["12602038"]}, {"Citation": "Bashir M, Bano A, Ijaz AS, Chaudhary BA. Recent developments and biological activities of N-substituted carbazole derivatives: a review. Molecules 2015;20:13496\u2013517.", "ArticleIdList": ["PMC6332089", "26213906"]}, {"Citation": "Bajaj YPS. Ochosia sp.: In vitro production of ellipticine an antitumor agent Chapter III.7. In: Ch\u00e9nieux C, Ramawat KG, Rideau M, eds. Medicinal and aromatic plants I. Biotechnology in agriculture and forestry. vol. 4 Berlin Heidelberg: Springer-Verlag; 1988,"}, {"Citation": "(a) Sinicropi MS, Iacopetta D, Rosano C, et. al. N-thioalkylcarbazoles derivatives as new anti-proliferative agents: synthesis, characterization, and molecular mechanism evaluation. J Enzyme Inhib Med Chem 2018;33:434\u201344.", "ArticleIdList": ["PMC6010102", "29383954"]}, {"Citation": "(b) Jiang H, Zhang WJ, Li PH, et.al. Synthesis and biological evaluation of novel carbazole-rhodanine conjugates as topoisomerase II inhibitors. Bioorg Med Chem Lett 2018;28:1320\u20133.", "ArticleIdList": ["29545100"]}, {"Citation": "(c) Saturnino C, Caruso A, Iacopetta D, et.al. Inhibition of human topoisomerase II by new N,N,N-trimethylethanammonium iodide alkylcarbazole derivatives. ChemMedChem 2018;13:2635\u201343.", "ArticleIdList": ["30347518"]}, {"Citation": "Elliptinium acetate, NCI Drug Dictionary , available at https://www.cancer.gov/publications/dictionaries/cancer-drug/def/elliptinium-acetate [last accessed 26 Apr 2018]."}, {"Citation": "Alectinib approved for (ALK) positive metastatic non-small cell lung cancer (NSCLC) , U.S. FDA, Approved Drugs, available at https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm584082.htm [last accessed 26 Apr 2018]."}, {"Citation": "Alecensa, alectinib, product information, EMA, Human medicines , available at http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004164/human_med_002068.jsp&mid=WC0b01ac058001d124 [last accessed 26 Jul 2018]."}, {"Citation": "Ruiz-Ceja KA, Chirino YI. Current FDA-approved treatments for non-small cell lung cancer and potential biomarkers for its detection. Biomed Pharmacother 2017;90:24\u201337.", "ArticleIdList": ["28340378"]}, {"Citation": "Midostaurin approved for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) , U.S. FDA, Approved Drugs, available at https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm555756.htm [last accessed 26 Apr 2018]."}, {"Citation": "Rydapt, midostaurin, product information, EMA, Human medicines , available at http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004095/human_med_002155.jsp&mid=WC0b01ac058001d124 [last accessed 26 Jul 2018]."}, {"Citation": "Stone RM, Manley PW, Larson RA, Capdeville R. Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. Blood Adv 2018;2:444\u201353.", "ArticleIdList": ["PMC5858474", "29487059"]}, {"Citation": "Gutierrez L, Jang M, Zhang T, et al. . Midostaurin reduces regulatory T cells markers in acute myeloid leukemia. Sci Rep 2018;8:17544.", "ArticleIdList": ["PMC6277419", "30510164"]}, {"Citation": "(a) Janosik T, Rannug A, Rannug U, et al. . Chemistry and properties of indolocarbazoles. Chem Rev 2018;118:9058\u2013128.", "ArticleIdList": ["30191712"]}, {"Citation": "(b) Tsutsumi LS, G\u00fcndisch D, Sun D. Carbazole scaffold in medicinal chemistry and natural products: a review from 2010-2015. Curr Top Med Chem 2016;16:1290\u2013313.", "ArticleIdList": ["26369811"]}, {"Citation": "(c) Shaikh MS, Karpoormath R, Thapliyal N, et al. . Current perspective of natural alkaloid carbazole and its derivatives as antitumor agents. Anticancer Agents Med Chem 2015;15:1049\u201365.", "ArticleIdList": ["25584693"]}, {"Citation": "Council of Scientific & Industrial Research (IN) Carbazole-bonded pyrrolo[2,1-c][1,4]benzodiazepine hybrids as potential anticancer agents and process for their preparation. US 8,927,538. 2015."}, {"Citation": "Bristol-Meyers Squibb Co Carbazole and carboline kinase inhibitors. US 0,058,988. 2012."}, {"Citation": "Philip Morris Products SA Carbazole and carboline derivatives, and preparation and therapeutic applications thereof. US 0,274,258. 2013."}, {"Citation": "University of Kansas Formulations of indole-3-carbinol derived antitumor agents with increased oral bioavailability. US 0,184,590. 2012."}, {"Citation": "CNRS Use of carbazole phenone derivatives for the treatment of cancer. FR 0,051,491. 2012."}, {"Citation": "Bristol-Meyers Squibb Co Carbazole compounds useful as bromodomain inhibitors. EP 2,961,748. 2018."}, {"Citation": "Health Research Inc Compounds and methods for treating cancers. US 0,024,083. 2016."}, {"Citation": "Incuron LCC Carbazole compounds and therapeutic uses of the compounds. US 9,108,916. 2015."}, {"Citation": "Novogen Ltd Functionalized and substituted carbazoles as anti-cancer agents. US 0,158,636. 2017."}, {"Citation": "GTx Inc Selective androgen receptor degrader (SARD) ligands and methods of use thereof. US 0,166,526. 2017."}, {"Citation": "Mitra K, Basu U, Khan I, et al. . Remarkable anticancer activity of ferrocenyl-terpyridine platinum (II) complexes in visible light with low dark toxicity. Dalton Trans 2014;43:751\u201363.", "ArticleIdList": ["24149439"]}, {"Citation": "Kolli SK, Prasad B, Babu PV, et al. . TFAA/H3PO4 mediated unprecedented N-acylation of carbazoles leading to small molecules possessing anti-proliferative activities against cancer cells. Org Biomol Chem 2014;12:6080\u20134.", "ArticleIdList": ["25006860"]}, {"Citation": "Shrungesh Kumar TO, Mahadevan KM, Kumara MN. Synthesis and cytotoxic studies of 2,3-dimethylindoles and tetrahydrocarbazoles. Int J Pharm Pharm Sci 2014;6:137\u201340."}, {"Citation": "Bandgar BP, Adsul LK, Chavan HV, et al. . Synthesis, biological evaluation, and molecular docking of N-{3-[3-(9-methyl-9H-carbazol-3-yl)-acryloyl]-phenyl}-benzamide/amide derivatives as xanthine oxidase and tyrosinase inhibitors. Bioorg Med Chem 2012;20:5649\u201357.", "ArticleIdList": ["22901670"]}, {"Citation": "Chou YS, Chang CC, Chang TC, et al. . Photo-induced antitumor effect of 3,6-bis(1-methyl-4-vinylpyridinium)carbazole diiodide. Biomed Res Int 2013;2013:1.", "ArticleIdList": ["PMC3591141", "23509809"]}, {"Citation": "G\u0142uszy\u0144ska A. Biological potential of carbazole derivatives. Eur J Med Chem 2015;94:405\u201326.", "ArticleIdList": ["25794500"]}, {"Citation": "Liao LJ, Kang CC, Jan IS, et al. . Improved diagnostic accuracy of malignant neck lumps by a simple BMVC staining assay. Analyst 2009;134:708\u201311.", "ArticleIdList": ["19305919"]}, {"Citation": "Gu Y, Lin D, Tang Y, et al. . A light-up probe targeting for Bcl-2 2345\u2009G-quadruplex DNA with carbazole TO. Spectrochim Acta A Mol Biomol Spectrosc 2018;191:180\u20138.", "ArticleIdList": ["29032342"]}, {"Citation": "Francisco CS, Rodrigues LR, Cerqueira NM, et al. . Novel benzopsoralen analogues: synthesis, biological activity and molecular docking studies. Eur J Med Chem 2014;87:298\u2013305.", "ArticleIdList": ["25262050"]}, {"Citation": "Yoon S, Kim J-H, Lee YJ, et al. . A novel carbazole derivative, MHY407, sensitizes cancer cells to doxorubicin-, etoposide-, and radiation treatment via DNA damage. Eur J Pharmacol 2012;697:24\u201331.", "ArticleIdList": ["23085270"]}, {"Citation": "Chen LC, Juang SH, Chang KM, et al. . Synthesis and antiproliferative evaluation of amide-containing anthraquinone, xanthone, and carbazole. Chem Pharm Bull (Tokyo) 2014;62:106\u201311.", "ArticleIdList": ["24390500"]}, {"Citation": "Ito C, Itoigawa M, Nakao K, et al. . Apoptosis of HL-60 leukemia cells induced by carbazole alkaloids isolated from Murraya euchrestifolia. J Nat Med 2012;66:357\u201361.", "ArticleIdList": ["21879331"]}, {"Citation": "Vega FM, Ridley AJ. Rho GTPases in cancer cell biology. FEBS Lett 2008;582:2093\u2013101.", "ArticleIdList": ["18460342"]}, {"Citation": "Lin W, Wang Y, Lin S, et al. . Induction of cell cycle arrest by the carbazole alkaloid Clauszoline-I from Clausena vestita DD Tao via inhibition of the PKC\u03b4 phosphorylation. Eur J Med Chem 2012;47:214\u201320.", "ArticleIdList": ["22093759"]}, {"Citation": "Saturnino C, Palladino C, Napoli M, et al. . Synthesis and biological evaluation of new N-alkylcarbazole derivatives as STAT3 inhibitors: preliminary study. Eur J Med Chem 2013;60:112\u20139.", "ArticleIdList": ["23287056"]}, {"Citation": "Peng WW, Zeng GZ, Song WW, Tan NH. A new cytotoxic carbazole alkaloid and two new other alkaloids from Clausena excavata. Chem Biodivers 2013;10:1317\u201321.", "ArticleIdList": ["23847076"]}, {"Citation": "Maneerat W, Ritthiwigrom T, Cheenpracha S, et al. . Bioactive carbazole alkaloids from Clausena wallichii roots. J Nat Prod 2012;75:741\u20136.", "ArticleIdList": ["22482432"]}, {"Citation": "\u00c7ift\u00e7i GA, Temel HE, Y\u0131ld\u0131r\u0131m \u015eU, et al. . Apoptotic effects of some carbazole derivatives on lung carcinoma and glioma cell lines. Med Chem Res 2013;22:3751\u20139."}, {"Citation": "Vlaar CP, Castillo-Pichardo L, Medina JI, et al. . Design, synthesis and biological evaluation of new carbazole derivatives as anti-cancer and anti-migratory agents. Bioorg Med Chem 2018;26:884\u201390.", "ArticleIdList": ["PMC5822041", "29358027"]}, {"Citation": "Kalathiya U, Padariya M, Baginski M. Molecular modeling and evaluation of novel dibenzopyrrole derivatives as telomerase inhibitors and potential drug for cancer therapy. IEEE/ACM Trans Comput Biol Bioinforma TCBB 2014;11:1196\u2013207.", "ArticleIdList": ["26357055"]}, {"Citation": "Sun L, Wu Y, Liu Y, et al. . Novel carbazole sulfonamide derivatives of antitumor agent: synthesis, antiproliferative activity and aqueous solubility. Bioorg Med Chem Lett 2017;27:261\u20135.", "ArticleIdList": ["27919655"]}, {"Citation": "Niu F, Liu Y, Jing Z, et al. . Novel carbazole sulfonamide microtubule-destabilizing agents exert potent antitumor activity against esophageal squamous cell carcinoma. Cancer Lett 2018;420:60\u201371.", "ArticleIdList": ["29408653"]}, {"Citation": "Panno A, Sinicropi MS, Caruso A, et al. . New trimethoxybenzamides and trimethoxyphenylureas derived from dimethylcarbazole as cytotoxic agents. Part I. J Heterocycl Chem 2014;51:294\u2013302."}, {"Citation": "Caruso A, Sinicropi MS, Lancelot J-C, et al. . Synthesis and evaluation of cytotoxic activities of new guanidines derived from carbazoles. Bioorg Med Chem Lett 2014;24:467\u201372.", "ArticleIdList": ["24374274"]}, {"Citation": "Rongved P, Kirsch G, Bouaziz Z, et al. . Indenoindoles and cyclopentacarbazoles as bioactive compounds: synthesis and biological applications. Eur J Med Chem 2013;69:465\u201379.", "ArticleIdList": ["24090918"]}, {"Citation": "Maneerat W, Ritthiwigrom T, Cheenpracha S, Laphookhieo S. Carbazole alkaloids and coumarins from Clausena lansium roots. Phytochem Lett 2012;5:26\u20138."}, {"Citation": "Santio NM, Vahakoski RL, Rainio E-M, et al. . Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion. Mol Cancer 2010;9:279.", "ArticleIdList": ["PMC2978147", "20958956"]}, {"Citation": "Aku\u00e9-G\u00e9du R, Letribot B, Saugues E, et al. . Kinase inhibitory potencies and in vitro antiproliferative activities of N-10 substituted pyrrolo[2,3-a]carbazole derivatives. Bioorg Med Chem Lett 2012;22:3807\u20139.", "ArticleIdList": ["22543026"]}, {"Citation": "Letribot B, Aku\u00e9-G\u00e9du R, Santio NM, et al. . Use of copper(I) catalyzed azide alkyne cycloaddition (CuAAC) for the preparation of conjugated pyrrolo[2,3-a]carbazole Pim kinase inhibitors. Eur J Med Chem 2012;50:304\u201310.", "ArticleIdList": ["22386260"]}, {"Citation": "Moreau P, Dezhenkova LG, Anizon F, et al. . New potent and selective inhibitor of Pim-1/3 protein kinases sensitizes human colon carcinoma cells to doxorubicin. Anticancer Agents Med Chem 2014;14:1228\u201336.", "ArticleIdList": ["25175798"]}, {"Citation": "Giraud F, Bourhis M, Nauton L, et al. . New N-1,N-10-bridged pyrrolo[2,3-a]carbazole-3-carbaldehydes: synthesis and biological activities. Bioorg Chem 2014;57:108\u201315.", "ArticleIdList": ["25305721"]}, {"Citation": "Giraud F, Aku\u00e9-G\u00e9du R, Nauton L, et al. . Synthesis and biological activities of 4-substituted pyrrolo [2,3-a]carbazole Pim kinase inhibitors. Eur J Med Chem 2012;56:225\u201336.", "ArticleIdList": ["22982527"]}, {"Citation": "Ichikawa S, Tatebayashi N, Matsuda A. Synthesis of C-glycosyl pyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as a scaffold for check point kinase 1 inhibitors. J Org Chem 2013;78:12065\u201375.", "ArticleIdList": ["24127858"]}, {"Citation": "Suchaud V, Gavara L, Saugues E, et al. . Identification of 1,6-dihydropyrazolo[4,3-c]carbazoles and 3,6-dihydropyrazolo[3,4-c]carbazoles as new Pim kinase inhibitors. Bioorg Med Chem 2013;21:4102\u201311.", "ArticleIdList": ["23735828"]}, {"Citation": "Vairavelu L, Zeller M, Prasad KR. Solvent-free synthesis of heteroannulated carbazoles: a novel class of anti-tumor agents. Bioorg Chem 2014;54:12\u201320.", "ArticleIdList": ["24698746"]}, {"Citation": "Song Z, Wang M, Zhang A. Alectinib: a novel second generation anaplastic lymphoma kinase (ALK) inhibitor for overcoming clinically-acquired resistance. Acta Pharm Sin B 2015;5:34\u20137.", "ArticleIdList": ["PMC4629211", "26579422"]}, {"Citation": "Kinoshita K, Asoh K, Furuichi N, et al. . Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802). Bioorg Med Chem 2012;20:1271\u201380.", "ArticleIdList": ["22225917"]}, {"Citation": "Kodama T, Tsukaguchi T, Yoshida M, et al. . Selective ALK inhibitor alectinib with potent antitumor activity in models of crizotinib resistance. Cancer Lett 2014;351:215\u201321.", "ArticleIdList": ["24887559"]}, {"Citation": "Ravichandiran P, Jegan A, Premnath D, et al. . Synthesis, molecular docking and cytotoxicity evaluation of novel 2-(4-amino-benzosulfonyl)-5H-benzo[b]carbazole-6,11-dione derivatives as histone deacetylase (HDAC8) inhibitors. Bioorg Chem 2014;53:24\u201336.", "ArticleIdList": ["24561820"]}, {"Citation": "Kok YY, Mooi LY, Ahmad K, et al. . Anti-tumor promoting activity and antioxidant properties of girinimbine isolated from the stem bark of Murraya koenigii S. Molecules 2012;17:4651\u201360.", "ArticleIdList": ["PMC6268782", "22522395"]}, {"Citation": "Padmaja P, Rao GK, Indrasena A, et al. . Synthesis and biological evaluation of novel pyrano[3,2-c]carbazole derivatives as anti-tumor agents inducing apoptosis via tubulin polymerization inhibition. Org Biomol Chem 2015;13:1404\u201314.", "ArticleIdList": ["25467166"]}, {"Citation": "Uvarani C, Jaivel N, Sankaran M, et al. . Axially chiral biscarbazoles and biological evaluation of the constituents from Murraya koenigii. Fitoterapia 2014;94:10\u201320.", "ArticleIdList": ["24444889"]}, {"Citation": "Das R, Bhattacharya K, Sarkar S, et al. . Mahanine synergistically enhances cytotoxicity of 5-fluorouracil through ROS-mediated activation of PTEN and p53/p73 in colon carcinoma. Apoptosis Int J Program Cell Death 2014;19:149\u201364.", "ArticleIdList": ["24052409"]}, {"Citation": "Das R, Bhattacharya K, Samanta SK, et al. . Improved chemosensitivity in cervical cancer to cisplatin: synergistic activity of mahanine through STAT3 inhibition. Cancer Lett 2014;351:81\u201390.", "ArticleIdList": ["24831030"]}, {"Citation": "Prudent R, Moucadel V, Nguyen C-H, et al. . Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2. Cancer Res 2010;70:9865\u201374.", "ArticleIdList": ["21118972"]}, {"Citation": "Mori R, Kato A, Komenoi K, et al. . Synthesis and in vitro antitumor activity of novel 2-alkyl-5-methoxycarbonyl-11-methyl-6H-pyrido[4,3-b]carbazol-2-ium and 2-alkylellipticin-2-ium chloride derivatives. Eur J Med Chem 2014;82:16\u201335.", "ArticleIdList": ["24863982"]}, {"Citation": "Sharma M, Agarwal A, Kishore D, Paliwal S. Quantitative structure activity relationship (QSAR) analysis of olivacine derivatives as topoisomerase inhibitors. Int J Pharm Pharm Sci 2012;4:198\u2013204."}, {"Citation": "Indumathi T, Muthusankar A, Shanmughavel P, Prasad KR. Synthesis of hetero annulated carbazoles: exploration of in vitro cytotoxicity and molecular docking studies. MedChemComm 2013;4:450."}, {"Citation": "Indumathi T, Prasad KR. Multicomponent synthesis of pyrido[2,3-a]carbazoles and cytotoxic activity. Med Chem Res 2014;23:4345\u201355."}, {"Citation": "Li B, Yue Z-Z, Feng J-M, et al. . Design and synthesis of pyrido[3,2-\u03b1]carbazole derivatives and their analogues as potent antitumor agents. Eur J Med Chem 2013;66:531\u20139.", "ArticleIdList": ["23835448"]}, {"Citation": "Hamilton PL, Arya DP. Natural product DNA major groove binders. Nat Prod Rep 2012;29:134\u201343.", "ArticleIdList": ["22183179"]}, {"Citation": "Murali K, Sparkes HA, Rajendra Prasad KJ. Synthesis of hetero annulated isoxazolo-, pyrido- and pyrimido carbazoles: screened for in vitro antitumor activity and structure activity relationships, a novel 2-amino-4-(3'-bromo-4'-methoxyphenyl)-8-chloro-11H-pyrimido[4,5-a]carbazole as an antitumor agent. Eur J Med Chem 2017;128:319\u201331.", "ArticleIdList": ["28213284"]}, {"Citation": "(a) Issa S, Walchshofer N, Kassab I, et al. . Synthesis and antiproliferative activity of oxazinocarbazole and N,N-bis(carbazolylmethyl)amine derivatives. Eur J Med Chem 2010; 45:4:2567\u201377.", "ArticleIdList": ["20236739"]}, {"Citation": "(b) Bouaziz Z, Issa S, Gentili J, et al. . Biologically active carbazole derivatives: focus on oxazinocarbazoles and related compounds. J Enzyme Inhib Med Chem 2015;30:180\u20138.", "ArticleIdList": ["24697298"]}, {"Citation": "Naik PN, Khan A, Kusurkar RS. Intramolecular Diels\u2013Alder reaction for the synthesis of tetracyclic carbazoles and isocanthines. Tetrahedron 2013;69:10733\u20138."}, {"Citation": "Shi F, Zeng X-N, Cao X-D, et al. . Design and diversity-oriented synthesis of novel 1, 4-thiazepan-3-ones fused with bioactive heterocyclic skeletons and evaluation of their antioxidant and cytotoxic activities. Bioorg Med Chem Lett 2012;22:743\u20136.", "ArticleIdList": ["22137847"]}, {"Citation": "Dunn D, Husten J, Ator MA, Chatterjee S. Novel poly (ADP-ribose) polymerase-1 inhibitors. Bioorg Med Chem Lett 2007;17:542\u20135.", "ArticleIdList": ["17074482"]}, {"Citation": "El Sayed MT, Ahmed KM, Mahmoud K, Hilgeroth A. Synthesis, cytostatic evaluation and structure activity relationships of novel bis-indolylmethanes and their corresponding tetrahydroindolocarbazoles. Eur J Med Chem 2015;90:845\u201359.", "ArticleIdList": ["25528338"]}, {"Citation": "Dieckmann S, Riedel R, Harms K, Meggers E. Pyridocarbazole-rhodium (III) complexes as protein kinase inhibitors. Eur J Inorg Chem 2012;2012:813\u201321."}, {"Citation": "Kastl A, Wilbuer A, Merkel AL, et al. . Dual anticancer activity in a single compound: visible-light-induced apoptosis by an antiangiogenic iridium complex. Chem Commun Camb Engl 2012;48:1863\u20135.", "ArticleIdList": ["22057186"]}, {"Citation": "G\u00e1belov\u00e1 A, Pol\u00e1kov\u00e1 V, Prochazka G, et al. . Sustained induction of cytochrome P4501A1 in human hepatoma cells by co-exposure to benzo[a]pyrene and 7H-dibenzo[c,g]carbazole underlies the synergistic effects on DNA adduct formation. Toxicol Appl Pharmacol 2013;271:1\u201312.", "ArticleIdList": ["23639521"]}, {"Citation": "Rozovsky A, Regozin E, Oron-Herman M, et al. . Synthesis of antitumor carbazole-amonafide structural hybrids. Eur J Org Chem 2015;2015:1811\u20138."}, {"Citation": "Esvan YJ, Giraud F, Pereira E, et al. . Synthesis and biological activity of pyrazole analogues of the staurosporine aglycon K252c. Bioorg Med Chem 2016;24:3116\u201324.", "ArticleIdList": ["27255178"]}, {"Citation": "Hudkins RL, Becknell NC, Zulli AL, et al. . Synthesis and biological profile of the pan-vascular endothelial growth factor receptor/tyrosine kinase with immunoglobulin and epidermal growth factor-like homology domains 2 (VEGF-R/TIE-2) inhibitor 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]carbazol-4-one (CEP-11981): a novel oncology therapeutic agent. J Med Chem 2012;55:903\u201313.", "ArticleIdList": ["22148921"]}, {"Citation": "Palanisamy SK, Rajendran NM, Marino A. Natural products diversity of marine Ascidians (Tunicates; Ascidiacea) and successful drugs in clinical development. Nat Prod Bioprospect 2017;7:1\u2013111.", "ArticleIdList": ["PMC5315671", "28097641"]}, {"Citation": "Acero N, Bra\u00f1a MF, A\u00f1orbe L, et al. . Synthesis and biological evaluation of novel indolocarbazoles with anti-angiogenic activity. Eur J Med Chem 2012;48:108\u201313.", "ArticleIdList": ["22182929"]}, {"Citation": "Sherer C, Snape TJ. Heterocyclic scaffolds as promising anticancer agents against tumours of the central nervous system: exploring the scope of indole and carbazole derivatives. Eur J Med Chem 2015;97:552\u201360.", "ArticleIdList": ["25466446"]}, {"Citation": "Fu P, Yang C, Wang Y, et al. . Streptocarbazoles A and B, two novel indolocarbazoles from the marine-derived actinomycete strain Streptomyces sp. FMA. Org Lett 2012;14:2422\u20135.", "ArticleIdList": ["22519738"]}, {"Citation": "Zembower DE, Xie Y, Koohang A, et al. . Methylenedioxy- and ethylenedioxy-fused indolocarbazoles: potent human topoisomerase I inhibitors and antitumor agents. Anticancer Agents Med Chem 2012;12:1117\u201331.", "ArticleIdList": ["22339065"]}, {"Citation": "Douara B, Esvan YJ, Pereira E, et al. . Synthesis and antiproliferative evaluation of glucosylated pyrazole analogs of K252c. Tetrahedron 2018;74:892\u2013901."}, {"Citation": "Pierce LT, Cahill MM, Winfield HJ, McCarthy FO. Synthesis and identification of novel indolo[2,3-a]pyrimido[5,4-c]carbazoles as a new class of anti-cancer agents. Eur J Med Chem 2012;56:292\u2013300.", "ArticleIdList": ["22910137"]}, {"Citation": "Gu W, Hao Y, Zhang G, et al. . Synthesis, in vitro antimicrobial and cytotoxic activities of new carbazole derivatives of ursolic acid. Bioorg Med Chem Lett 2015;25:554\u20137.", "ArticleIdList": ["25537271"]}, {"Citation": "Iman V, Mohan S, Abdelwahab SI, et al. . Anticancer and anti-inflammatory activities of girinimbine isolated from Murraya koenigii. Drug Des Devel Ther 2016;Volume11:103\u201321.", "ArticleIdList": ["PMC5207336", "28096658"]}, {"Citation": "Diaz P, Horne E, Xu C, et al. . Modified carbazoles destabilize microtubules and kill glioblastoma multiform cells. Eur J Med Chem 2018;159:74\u201389.", "ArticleIdList": ["PMC6690746", "30268825"]}]}], "History": [{"Year": "2019", "Month": "7", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "7", "Day": "22"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31328585", "PMC6691762", "10.1080/14756366.2019.1640692"]}}]}